Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. Smith & Nephew Plc
  6. News
  7. Summary
    SN.   GB0009223206

SMITH & NEPHEW PLC

(SN.)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Berenbreg Lifts Smith & Nephew PT, Maintains Buy Rating

12/17/2021 | 07:50am EDT
share with twitter
share with LinkedIn
share with facebook


© MT Newswires 2021
All news about SMITH & NEPHEW PLC
05/05Berenberg Trims Smith & Nephew's PT, Keeps Buy Rating
MT
04/30SMITH & NEPHEW PLC : Monthly statement on outstanding equity shares and voting rights
CO
04/29European ADRs Nudge Higher in Friday Trading
MT
04/29Citigroup Keeps Smith & Nephew At Neutral, Lifts PT
MT
04/29UBS Lifts Smith & Nephew PT, Keeps Neutral Rating
MT
04/28European ADRs Nudge Lower in Thursday Trading
MT
04/28Smith & Nephew plc Reports Revenue Results for the First Quarter of 2022
CI
04/28Standard Chartered leads FTSE 100 higher in earnings-driven session
RE
04/28TRANSCRIPT : Smith & Nephew plc, Q1 2022 Sales/ Trading Statement Call, Apr 28, 2022
CI
04/28SMITH & NEPHEW : +Nephew First Quarter 2022 Trading Update
PU
More news
Analyst Recommendations on SMITH & NEPHEW PLC
More recommendations
Financials (USD)
Sales 2022 5 338 M - -
Net income 2022 486 M - -
Net Debt 2022 2 086 M - -
P/E ratio 2022 28,1x
Yield 2022 2,22%
Capitalization 13 812 M 13 812 M -
EV / Sales 2022 2,98x
EV / Sales 2023 2,81x
Nbr of Employees 18 369
Free-Float 98,9%
Chart SMITH & NEPHEW PLC
Duration : Period :
Smith & Nephew Plc Technical Analysis Chart | SN. | GB0009223206 | MarketScreener
Technical analysis trends SMITH & NEPHEW PLC
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 14
Last Close Price 15,86 $
Average target price 18,55 $
Spread / Average Target 17,0%
EPS Revisions
Managers and Directors
Deepak S Nath Chief Executive Officer & Director
Anne-Francoise Nesmes Chief Financial Officer & Executive Director
Roberto Quarta Chairman
Vasant Padmanabhan President-Research & Development
Paul Connolly President-Global Operations
Sector and Competitors
1st jan.Capi. (M$)
SMITH & NEPHEW PLC-1.62%13 812
STRYKER CORPORATION-13.15%87 826
INSPIRE MEDICAL SYSTEMS, INC.-23.54%4 853
AXONICS, INC.-10.82%2 351
DOUBLE MEDICAL TECHNOLOGY INC.-33.09%2 111
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.-27.64%1 936